research Halo Nevi, Vitiligo, and Diffuse Alopecia Areata Associated with Tocilizumab Therapy
Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.
Search
forProducts matching "effect studies"
Tracking 6 products like 10 Maxogen-S, 100 RU58841 Powder, 183 PROPECIA 1MG/*28 TABL, 183 PROPECIA 1MG/*28 TABL and 183 PROPECIA 1MG/*28 TABL from by companies like MinoxidilMax, OnlinePharmacy-BG, Inhouse Pharmacy and oasisstad.net. View all 6 products »
Sort by
Research
360-390 / 1000+ results 
research Antiandrogenic Drugs: A Therapeutic Option for Frontal Fibrosing Alopecia Patients
Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.
research Persistent Sexual Dysfunction and Depression in Finasteride Users for Male Pattern Hair Loss: A Serious Concern or Red Herring?
Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.
research Study of Serum Vitamin D Levels in Men with Premature Androgenetic Alopecia
Men with early hair loss have lower vitamin D levels.
research Influence of Clipping and Chemical Epilation on Hair Growth in Mice
Certain treatments can speed up local hair growth in mice but don't change the overall hair growth pattern.
research Vitamins A, B, C, and D: A Short Review for the Dermatologist
Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.
research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
The study suggests pandemic stress might worsen or trigger hair loss problems.
research Three Months Extended-Release Microspheres Prepared by Multi-Microchannel Microfluidics in Beagle Dog Models
A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.
research Side Effects Related to 5 Alpha-Reductase Inhibitor Treatment of Hair Loss in Women: A Review
The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.
research Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?
Topical minoxidil might potentially cause vision problems, but more research is needed.
research Runx1 Transcription Factor Is Involved in the Regulation of KAP5 Gene Expression in Human Hair Follicles
Runx1 helps control the KAP5 gene in human hair follicles.
research Alopecia Secondary to Severe Discoid Lupus Responding to Anifrolumab
Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.
research Acne Exacerbation After Tofacitinib Treatment for Alopecia Areata
Tofacitinib treatment for hair loss may worsen acne.
research Hyperpigmentation Following Treatment of Frontal Fibrosing Alopecia
A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.
research Sodium Divalproate in Low Alternating Daily Doses for Migraine Prevention: A Retrospective Study
Low alternating doses of sodium divalproate reduced migraine frequency but caused weight gain.
research Alopecia Areata After COVID-19 Vaccines
Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.
research Bicalutamide and the New Perspectives for Female Pattern Hair Loss Treatment: What Dermatologists Should Know
Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.
research Platelet Rich Plasma Hybridized Adipose Transplant for the Treatment of Hair Loss: A Case Series
PHAT may improve hair growth better than PRP alone.
research Association Between Vitamin D and Zinc Levels With Alopecia Areata Phenotypes at a Tertiary Care Center
Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.
research Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.
research Molybdenum Nanoparticles as a Potential Topical Medication for Alopecia Treatment Through Antioxidant Pathways That Differ from Minoxidil
Nano-sized molybdenum may help treat hair loss and works well with minoxidil.
research Successful Response to a Combination of Intralesional Methotrexate and Fractional CO2 Laser in Refractory Alopecia Areata: Case Report
A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.
research Botulinum Toxins in Medical and Cosmetic Dermatology
Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.
research Topical Cetirizine 1% for Treatment of Androgenetic Alopecia
Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.
research Valproic Acid and Alopecia: A Two-Edged Sword
Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.
research Agomelatine May Alleviate Valproate-Induced Hair Loss
Agomelatine might help stop hair loss caused by valproate.
research Alopecia Areata Associated With Haloperidol Decanoate Long-Acting Injection
Haloperidol decanoate can cause alopecia areata.
research Alopecia and Amphetamine Use: Reply
Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.
research Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
JAK inhibitors show promise for treating various skin diseases.
research Efficacy of Spironolactone as Adjunctive Therapy to Sodium Valproate in Bipolar-I Disorder: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.